Amphastar Pharma Uncategorized Contracts & Agreements
9 Contracts & Agreements
- Amendment to Contact Research Agreement by and between Amphastar Pharmaceuticals, Inc. and Nanjing Hanxin Pharmaceutical Technology Co., Ltd., dated March 8, 2023 (Filed With SEC on May 9, 2023)
- Contract Research Agreement by and between Amphastar Pharmaceuticals, Inc. and Nanjing Hanxin Pharmaceutical Technology Co., Ltd, dated July 5, 2022 (Filed With SEC on November 8, 2022)
- Contract Manufacturing Agreement by and between Amphastar Nanjing Pharmaceuticals, Inc. and Nanjing Hanxin Pharmaceutical Technology Co., Ltd, dated April 19, 2022 (Filed With SEC on August 9, 2022)
- Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 15, 2021)
- Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 16, 2020)
- Partnership Agreement by and between Zhang Chongqing, Bill Zhang and Applied Physics & Chemistry Laboratories, Inc. dated July 27, 2018 (Filed With SEC on August 9, 2018)
- CORPORATE RESOLUTION TO BORROW / GRANT COLLATERAL (Filed With SEC on May 10, 2016)
- Transfer Contract for the Right to the Use of State-owned Land NKTZHZ [2010] No. (016) (Filed With SEC on May 20, 2014)
- Transfer Contract for the Right to the Use of State-owned Land NKTZHZ [2009] No. (012) (Filed With SEC on May 20, 2014)